Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-207-000"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20110216.11.3-207-000"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spoken text |
"The quality of medicinal products is crucial to ensure safety, and to give peace of mind to consumers. It is clear that there is a rising threat to the health of our constituents as a result of these products flooding the market, especially with falsifications becoming more sophisticated year on year. This is a public health crisis on a global scale. It is currently estimated that perhaps 15% of the global medicine supply is counterfeit, while it is estimated that in some developing countries over 30% of medicines on sale may be counterfeit. The public needs to be 100% sure that the products they consume are safe and fit for purpose. The use of falsified medicines can have a serious detrimental impact on a patient’s health, in some cases leading to death. It is clear that a comprehensive strategy on tackling this issue is vital, both at national and international level, in order to ensure that high standards of public health and safety are maintained."@en1
|
lpv:spokenAs | |
lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples